
You are here
Consultations
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Filters
Status
Categories
- Advertising (8) Apply Advertising filter
- Australian Register of Therapeutic Goods (ARTG) (1) Apply Australian Register of Therapeutic Goods (ARTG) filter
- Biologicals (9) Apply Biologicals filter
- Blood and blood components (4) Apply Blood and blood components filter
- Complementary medicines (22) Apply Complementary medicines filter
- Cosmetics (2) Apply Cosmetics filter
- Disinfectants/Sterilants (4) Apply Disinfectants/Sterilants filter
- Import/Export (1) Apply Import/Export filter
- Labelling/Packaging (23) Apply Labelling/Packaging filter
- Legislation (20) Apply Legislation filter
- Listed medicines (2) Apply Listed medicines filter
- Manufacturing (11) Apply Manufacturing filter
- Medical devices safety (1) Apply Medical devices safety filter
- Medical devices/IVDs (48) Apply Medical devices/IVDs filter
- Medicinal cannabis (1) Apply Medicinal cannabis filter
- Medicines (1) Apply Medicines filter
- OTC medicines (31) Apply OTC medicines filter
- Prescription medicines (25) Apply Prescription medicines filter
- Safety of medicines & medical devices (2) Apply Safety of medicines & medical devices filter
- Scheduling (37) Apply Scheduling filter
- Therapeutic Goods Administration (TGA) (6) Apply Therapeutic Goods Administration (TGA) filter
- Therapeutic goods regulation (6) Apply Therapeutic goods regulation filter
Mechanisms to maintain the currency of approved Product Information (PI) and Consumer Medicine Information (CMI)
Closed on 13 June 2013
Evaluating the feasibility of a new-to-market risk communication scheme for therapeutic goods
Closed on 13 June 2013
Proposed amendments to the new regulatory framework for In Vitro Diagnostic medical devices (IVDs)
Closed on 7 June 2013
Regulation Impact Statement: Changes to premarket assessment requirements for medical devices
Closed on 3 June 2013
ARGCM Part C: Evaluation of complementary medicine substances for use in listed medicines
Closed on 4 May 2013
Cetirizine: proposed advisory statements for medicines
Closed on 3 May 2013
Review of the arrangements for the scheduling of medicines and poisons
Closed on 29 April 2013
Permitted (coded) indications for listed medicines
Closed on 15 March 2013
Minor variations to prescription medicines: guidance and application forms
Closed on 22 February 2013
ARGCM Part B: Listed medicines
Closed on 18 February 2013